老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
麥科田
8.225
-0.215
-2.55%
手動刷新
成交量：
12.52萬
成交額：
103.35萬
市值：
44.30億
市盈率：
78.33
高：
8.430
開：
8.395
低：
8.200
收：
8.440
52周最高：
10.900
52周最低：
8.200
股本：
5.39億
香港流通股本：
4.79億
量比：
0.71
換手率：
0.03%
股息：
- -
股息率：
- -
每股收益(LYR):
0.105
淨資產收益率：
--
總資產收益率：
--
市淨率：
2.00
市盈率(LYR):
78.33
市銷率:
2.25
資料載入中...
總覽
公司
新聞資訊
公告
麥科田（02041）公布董事會薪酬與考核委員會工作細則 明確成員構成及職責
公告速递
·
09/04
麥科田(02041)公布審計委員會工作細則 H股上市當日起實施
公告速递
·
09/04
本周3只新股申購，「國產GPU四小龍」之一周三抽新股
澎湃新闻
·
08/31
麥科田啓動港股IPO全球發售：2025年剛扭虧為盈 今年一季度又虧了 無基石護航 後市難料
新浪证券
·
08/28
新股消息 | 麥科田(02041)今日起招股， 2023-2025年間複合增長率達38.9%
智通财经
·
08/28
新股招股｜麥科田今日起至9月2日招股，一手入場費1557.55 港元
老虎资讯综合
·
08/28
麥科田(02041)8月28日至9月2日招股 擬全球發售3891.06萬股H股
智通财经
·
08/28
美卡醫療啓動全球發售：每股發售價15.42港元，擬募資淨額約4.96億港元
公告速递
·
08/28
麥科田生物全球發售：發行3,891.1萬股香港公開發售股份，發售價每股15.42港元
公告速递
·
08/28
深圳麥科田生物醫療技術股份有限公司（02041）啓動港股招股 計劃發行3,891.06萬股H股
公告速递
·
08/28
增長超130%！麥科田憑什麼讓港股「無法忽視「？
智通财经
·
08/25
IPO周報｜本周4只新股申購，國內軸承製造龍頭來了
澎湃新闻
·
08/24
新股消息 | 醫療器械商麥科田通過港交所聆訊 三大業務線全球佈局、多品類領先
智通财经
·
08/22
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/02041/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"02041","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02041\",,,,,undefined,":{"symbol":"02041","market":"HK","secType":"STK","nameCN":"麥科田","latestPrice":8.225,"timestamp":1789527773217,"preClose":8.44,"halted":0,"volume":125200,"delay":0,"changeRate":-0.025473933649289085,"floatShares":479221686,"shares":538626686,"eps":0.105,"marketStatus":"交易中","change":-0.215,"latestTime":"09-16 11:04:25","open":8.395,"high":8.43,"low":8.2,"amount":1033464,"amplitude":0.027251,"askPrice":8.23,"askSize":32500,"bidPrice":8.225,"bidSize":8600,"shortable":0,"etf":0,"ttmEps":0.086,"tradingStatus":2,"nextMarketStatus":{"tag":"午間休市","tradingStatus":4,"beginTime":1789531200000},"marketStatusCode":2,"adr":0,"listingDate":1788710400000,"exchange":"SEHK","adjPreClose":8.44,"openAndCloseTimeList":[[1789522200000,1789531200000],[1789534800000,1789545600000]],"volumeRatio":0.708892,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02041\",,,,,undefined,":{"symbol":"02041","floatShares":479221686,"roa":"--","roe":"--","lyrEps":0.105,"volumeRatio":0.708892,"shares":538626686,"dividePrice":0,"high":8.43,"amplitude":0.027251,"preClose":8.44,"low":8.2,"week52Low":8.2,"pbRate":"2.00","psRate":"2.25","week52High":10.9,"institutionHeld":0,"latestPrice":8.225,"committee":-0.581509,"eps":0.105,"divideRate":0,"volume":125200,"delay":0,"ttmEps":0.086,"open":8.395,"prevYearClose":15.42,"prevWeekClose":8.78,"prevMonthClose":15.42,"prevQuarterClose":15.42,"fiveDayClose":8.9,"twentyDayClose":15.42,"sixtyDayClose":15.42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02041\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02041\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02041\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02041\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02041","date":"2026-09-15","current":95.639535,"percent":0.166667,"low":93.363667,"twenty":96.235382,"median":99.552782,"eighty":101.691807,"high":108.122149,"avg":99.770762,"sd":4.392976,"marketCap":4546009229},"quantilePoints":[{"date":"2026-09-11","current":99.299195,"twenty":99.502065,"median":100.631135,"eighty":103.19001,"marketCap":4729142303},{"date":"2026-09-15","current":95.469429,"twenty":96.235382,"median":99.552782,"eighty":101.691807,"marketCap":4546009229}],"updateTime":1789527865915},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02041\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1193929381","title":"麥科田（02041）公布董事會薪酬與考核委員會工作細則 明確成員構成及職責","url":"https://stock-news.laohu8.com/highlight/detail?id=1193929381","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193929381?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 06:26","pubTimestamp":1788474375,"startTime":"0","endTime":"0","summary":"深圳麦科田生物医疗技术股份有限公司近日发布《董事会薪酬与考核委员会工作细则》。文件显示，公司已设立董事会薪酬与考核委员会，并就其组成、职责、决策程序及议事规则作出具体规定，自公司发行的H股于香港联合交易所有限公司主板挂牌上市之日起生效实施。委员会由不少于三名董事组成，其中独立非执行董事占多数。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151324928","title":"麥科田(02041)公布審計委員會工作細則 H股上市當日起實施","url":"https://stock-news.laohu8.com/highlight/detail?id=1151324928","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151324928?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 06:21","pubTimestamp":1788474103,"startTime":"0","endTime":"0","summary":"2026年9月，麦科田生物医疗技术股份有限公司董事会审议通过《董事会审计委员会工作细则》，自公司 H 股股票在香港联合交易所主板挂牌上市之日起生效。根据新的细则，麦科田将进一步完善公司治理结构，强化董事会对经理层的监督职能，并提升内部、外部审计的独立性与专业性。麦科田表示，此举旨在通过制度化建设进一步保障财务信息披露的真实、完整、准确，提升内部控制和风险管理水平，为即将到来的香港资本市场运作奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663684028","title":"本周3只新股申購，「國產GPU四小龍」之一周三抽新股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663684028","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663684028?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 07:48","pubTimestamp":1788133680,"startTime":"0","endTime":"0","summary":"本周新股申购迎来又一家国产算力芯片厂商。澎湃新闻根据Wind及公开信息梳理统计，本周有4只新股安排申购，分别为海南百迈科医疗科技股份有限公司、上海燧原科技股份有限公司、苏州信诺维医药科技股份有限公司。去年12月，“国产GPU四小龙”中的摩尔线程、沐曦股份已先后在科创板上市。随着燧原科技开启申购，“国产GPU四小龙”即将齐聚资本市场。上周，共有2只新股上市。本周，北交所将继续开审。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-08-31/doc-iniqehxc9185673.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-31/doc-iniqehxc9185673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ARTY","AGIX","AIPO","IPOS","LNGR","MEDX","02041","QTOC","CHAT","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662061434","title":"麥科田啓動港股IPO全球發售：2025年剛扭虧為盈 今年一季度又虧了 無基石護航 後市難料","url":"https://stock-news.laohu8.com/highlight/detail?id=2662061434","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662061434?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 18:12","pubTimestamp":1787911920,"startTime":"0","endTime":"0","summary":"8月28日，深圳麦科田生物医疗技术股份有限公司宣布启动港股全球发售，拟发行3891.06万股H股，发售价定为每股15.42港元，预计9月7日在港交所挂牌上市。但2026年第一季度的业绩又出现了反复。从“战略性亏损”到盈利再反复麦科田曾在2022年至2024年经历连续三年亏损。2025年的扭亏为盈，被解读为公司已跨越“战略性亏损”的临界点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-08-28/doc-inipwhrr9070076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","KCAI","BK4127","KCE","BK4585","IPOS","REDS","FRHC","VXUS","02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662756053","title":"新股消息 | 麥科田(02041)今日起招股， 2023-2025年間複合增長率達38.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662756053","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662756053?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 11:55","pubTimestamp":1787889311,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，8月28日，麦科田发布公告，公司拟全球发售3891.06万股股份，其中香港发售股份389.11万股，国际发售股份3501.95万股。麦科田预计于2026年9月7日在主板上市，摩根士丹利亚洲有限公司、华泰金融控股(香港)有限公司为联席保荐人。麦科田是一家全球医疗器械提供商，可满足医疗机构内广泛的临床科室、病房和诊所以及社区卫生中心、检验机构和家庭护理场景的临床需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1487761.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107995485","title":"新股招股｜麥科田今日起至9月2日招股，一手入場費1557.55 港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1107995485","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107995485?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 08:43","pubTimestamp":1787877794,"startTime":"0","endTime":"0","summary":"每手100股H股，一手入场费1557.55 港元，预期H股将于2026年9月7日(星期一)挂牌。集团的收入由2023年的人民币13.13亿元增加至2025年的人民币16.19亿元，并由截至2025年3月31日止三个月的人民币3.55亿元进一步增加至2026年同期的人民币4.22亿元。于截至2026 年3月31日止三个月，集团取得净亏损人民币250万元，主要由于集团根据首次公开发售前购股权计划作出股份支付人民币2510万元及产生上市开支人民币1250万元。","market":"us","thumbnail":"https://community-static.tradeup.com/news/6a1fc8f3be741038c54e99953f811f82","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/6a1fc8f3be741038c54e99953f811f82"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3430ee0e05254278b5a3da84a7b77b4c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"新股招股｜麦科田今日起至9月2日招股，一手入场费1557.55 港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662397430","title":"麥科田(02041)8月28日至9月2日招股 擬全球發售3891.06萬股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662397430","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662397430?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 06:51","pubTimestamp":1787871072,"startTime":"0","endTime":"0","summary":"集团的收入由2023年的人民币13.13亿元增加至2025年的人民币16.19亿元，并由截至2025年3月31日止三个月的人民币3.55亿元进一步增加至2026年同期的人民币4.22亿元。于2025年，集团扭亏为盈，取得净利润人民币5070万元，主要由于所有业务单元的销售增长，加上生产及营运效率提升。于截至2026 年3月31日止三个月，集团取得净亏损人民币250万元，主要由于集团根据首次公开发售前购股权计划作出股份支付人民币2510万元及产生上市开支人民币1250万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1487632.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"麦科田(02041)8月28日至9月2日招股 拟全球发售3891.06万股H股","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124306994","title":"美卡醫療啓動全球發售：每股發售價15.42港元，擬募資淨額約4.96億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124306994","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124306994?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 06:28","pubTimestamp":1787869714,"startTime":"0","endTime":"0","summary":"公司总部位于中国深圳，并在全球超过140个国家和地区开展业务。2026年第一季度的收入约为人民币4.22亿元，高于2025年同期的3.55亿元，但因股份支付及上市费用增加，产生净亏损约人民币0.03亿元。本次全球发售涵盖香港公开发售及国际发售，共计发行3,891.06万股H股，约占扩大后已发行股本的7.2%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美卡医疗启动全球发售：每股发售价15.42港元，拟募资净额约4.96亿港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124639329","title":"麥科田生物全球發售：發行3,891.1萬股香港公開發售股份，發售價每股15.42港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124639329","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124639329?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 06:19","pubTimestamp":1787869147,"startTime":"0","endTime":"0","summary":"深圳麦科田生物医疗技术股份有限公司主要从事生命支持、微创介入和体外诊断等三大医疗器械业务，产品覆盖注射泵及输注工作站、麻醉机、微创介入耗材、检测分析仪与体外诊断试剂等领域。根据公告，2023年至2025年，公司收入分别为人民币13.133亿元、人民币13.993亿元和人民币16.192亿元，2025年较2024年增长23.2%。发行完成后，公司总股本将增至约5.39亿股。公司假设按每股15.42港元的发售价并扣除相关开支后，预期从全球发售获得的所得款项净额约为4.96亿港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"麦科田生物全球发售：发行3,891.1万股香港公开发售股份，发售价每股15.42港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108927095","title":"深圳麥科田生物醫療技術股份有限公司（02041）啓動港股招股 計劃發行3,891.06萬股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=1108927095","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108927095?lang=zh_tw&edition=fundamental","pubTime":"2026-08-28 06:05","pubTimestamp":1787868348,"startTime":"0","endTime":"0","summary":"2026年8月28日，深圳麦科田生物医疗技术股份有限公司在港交所披露《全球发售》公告，正式启动香港首次公开募股。本次全球发售总规模为38,910,600股H股。根据招股说明书，深圳麦科田生物医疗技术股份有限公司2025年全年实现收入16.19亿元人民币，符合港交所上市规则第8.05条市值╱收益测试中“最近一个财年收益不少于5亿港元”的要求。届时，深圳麦科田生物医疗技术股份有限公司将正式成为港股市场医械领域的新成员。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662207457","title":"增長超130%！麥科田憑什麼讓港股「無法忽視「？","url":"https://stock-news.laohu8.com/highlight/detail?id=2662207457","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662207457?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 09:26","pubTimestamp":1787621214,"startTime":"0","endTime":"0","summary":"近日赴港上市的麦科田医疗，恰好站上“出海”与“创新”这两大风口。2023至2025年，麦科田总营收分别为13.13亿元、13.99亿元和16.19亿元，年复合增长率约11%;2026年前3个月营收同比增长19.1%至4.22亿元。2025年经调整净利润达1.29亿元，2026年前三个月经调整利润3500万元，远超去年同期的1510万元，经调整期内利润增长超130%;经调整EBITDA亦增长至2.90亿元，2023-2025年间复合增长率达38.9%。小结行业政策红利与业绩拐点双重叠加，让麦科田的本次IPO成为一个颇具吸引力的投资窗口。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484786.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","BK4585","02041","VXUS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661908241","title":"IPO周報｜本周4只新股申購，國內軸承製造龍頭來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2661908241","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661908241?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 08:14","pubTimestamp":1787530440,"startTime":"0","endTime":"0","summary":"本周新股申购迎来4家细分领域头部公司。Wind资料显示，洛轴股份主营轴承及相关零部件的研发、生产和销售，是中国轴承行业规模最大的综合性轴承制造企业之一。上周，共有6只新股上市。本周，北交所将继续开审。上周，湖南裕能新能源电池材料股份有限公司首次递交港股招股书。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-08-24/doc-inipkmaa6265702.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-24/doc-inipkmaa6265702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02041","KCE","FRHC","IPOS","BK4127","REDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661216385","title":"新股消息 | 醫療器械商麥科田通過港交所聆訊 三大業務線全球佈局、多品類領先","url":"https://stock-news.laohu8.com/highlight/detail?id=2661216385","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661216385?lang=zh_tw&edition=fundamental","pubTime":"2026-08-22 14:35","pubTimestamp":1787380509,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","BK1574","02041","09996","BK1100"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":33,"code":"91000000","status":"200"}]}}